Objective: To determine the clinical and haematological factors associated with treatment and outcome of chronic myeloid leukaemia (CML) at Kenyatta National Hospital.
Design: Retrospective survey of patients treated for chronic myeloid leukaemia.
Setting: Kenyatta National hospital, Nairobi, Kenya, between April 1990 and August 2000.
Subjects: Patients with chronic myeloid leukaemia.
Results: One hundred and four patients, 55 males and 49 females, age range 10-72 years with a median age of 35 years. Treatment with busulphan getting less popular in favour of hydroxyurea. Median follow-up 20 months with none of the clinical and haematological parameters impacting significantly on duration of follow-up.
Conclusion: CML occurs at a younger age-group in Kenya, and none of the clinical or haematological parameters appears to impact on follow-up duration.